New Drug for Use in Bone Scans Approved; provides an alternative to radioactive tracer that is currently in short supply
(Posted: 02/01/2011) - The FDA has approved a New Drug Application (NDA) from NCI for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone scans. In contrast to Technetium-99m, which has been the only approved radioactive tracer for bone scans, Sodium Fluoride F18 is not subject to the supply problems.
Source: www.cancer.gov
No comments:
Post a Comment